LEADERSHIP BUSINESS DEV RESEARCH REGULATORY VERIFIED DECISION
Solutions

Every role in your organization is making decisions on incomplete intelligence. Right now.

Cortex delivers verified, role-specific intelligence to every function that needs it — before the gap between what they know and what they should know becomes a liability.

By Function

Leadership & Strategy

Your CSO is making portfolio decisions based on intelligence that was current three weeks ago. A competitor acquisition closed yesterday. A regulatory pathway shifted last Friday. The board meeting is Thursday. Cortex ensures leadership operates on real-time strategic intelligence — not last month's assumptions.

Delivers: Strategic briefings, competitive landscape monitoring, portfolio intelligence, board-ready summaries.

Strategic Brief
Ready
Period
March 2026
Key Movements
2 competitor acquisitions, 1 FDA approval in target area
Regulatory
EMA pathway clarity guidance published
Priority
HIGH Portfolio expansion opportunity
BD Signal
Active
Target
XYZ Therapeutics
Signal Type
Licensing availability
Stage
Phase 2 complete
Action
Preliminary discussion recommended

Business Development & Licensing

The licensing window for that Phase 2 asset opened 11 days ago. Two competitors already know. Your BD team will find out in a conference hallway next quarter — unless Cortex tells them first. It is already monitoring deal flow, partnership signals, and asset availability across your target landscape.

Delivers: Partner monitoring, deal landscape tracking, asset comparison, licensing signals.

Research & Scientific Strategy

A competitor's Phase 2b readout just changed the competitive landscape in your therapeutic area. Your research lead will read about it in a journal next month. Cortex detected it in real time and is already mapping the implications for your pipeline positioning.

Delivers: Trial monitoring, scientific signals, therapeutic area intelligence, pipeline visibility.

Trial Readout
Announced
Trial
ACHIEVE Phase 2b
Phase
2b Complete
Endpoint
Primary: Met
Impact
HIGH Competitive advance
Regulatory Alert
Active
Agency
FDA CDER
Action
Guidance published
Subject
Clinical trial endpoints in rare disease
Impact
HIGH Protocol review needed

Regulatory & Compliance

An FDA guidance change can invalidate six months of filing preparation overnight. Most regulatory teams discover these shifts after the compliance pressure is already real. Cortex monitors FDA and EMA actions continuously and flags timeline-affecting changes before they cascade into operational disruption.

Delivers: FDA/EMA tracking, guidance monitoring, compliance alerts, filing timeline intelligence.

For Healthcare Practitioners

Your patients deserve decisions informed by intelligence that is current — not six months old.

New therapies are approved. Clinical trials shift treatment protocols. Drug interactions emerge from post-market surveillance. The practitioners who see these signals first make better decisions for their patients. Cortex delivers structured, verified intelligence directly to your practice — continuously.

Therapy Monitoring
Track emerging peptide therapies, clinical trials, and treatment protocol updates in real time.
Regulatory Alerts
FDA approval notifications, guidance changes, and compliance updates delivered to your practice.
Practice Briefings
Structured weekly intelligence briefs tailored to your specialty and patient population.
Request Access

Available for qualified healthcare practitioners and clinical organizations.